Showing results (1981-1990 of 6,919) with videos related to
Sort By:
Pageof 692
Archives of Toxicology|March 29, 2008
The response of Ty1 test to genotoxinsM Pesheva, O Krastanova, R Stamenova, et al.Archives of Toxicology|April 13, 2025
Alterations in acetylcholinesterase activity and oxidative stress parameters induced by pure cylindrospermopsin in brain of orally exposed rats and determination of potential metabolitesCristina Plata-Calzado, Ana I Prieto, Ana M Cameán, et al.Archives of Toxicology|April 4, 2025
Biomarker-based approach to human exposure assessment of furan in foodC Kalisch, M Reiter, A MallyArchives of Toxicology|April 28, 2025
Application of a high-density microelectrode array assay using a 3D human iPSC-derived brain microphysiological system model for in vitro neurotoxicity screening of environmental compoundsKelly E Carstens, Elena Gronskaya, David Jäckel, et al.Archives of Toxicology|April 24, 2025
Towards a good environmental status: a 4-year monitoring study on the contamination of the Bay of Luebeck with energetic compounds prior to munitions remediationTobias H Bünning, Jennifer S Strehse, Edmund MaserArchives of Toxicology|April 18, 2025
Extension and validation of a physiologically based toxicokinetic model for risk assessment of aluminium exposure in humansNiklas Hartung, Gaby Wangorsch, Wilhelm Huisinga, et al.Archives of Toxicology|May 7, 2025
Delayed complications of sulfur mustard poisoning: a focus on inflammation and telomere footprintAlireza Nourazarian, Seyed Mohsen Aghaei-Zarch, Yasin PanahiArchives of Toxicology|May 3, 2025
Carfentanil stabilizes µ opioid receptor conformations that are ultra-efficient in inhibiting cAMP, resistant to naloxone or nalmefene but sensitive to naltrexoneFranziska Endt, Tao Guo, Dirk Steinritz, et al.Archives of Toxicology|June 19, 2025
Characterizing the in vitro metabolic features of seven α-pyrrolidinophenone-derived synthetic cathinone-type new psychoactive substancesXuan Luo, Fang Zhang, Kejian Huang, et al.Archives of Toxicology|June 3, 2025
An update on the involvement of inflammatory mediators in Parkinson's disease pathogenesisOyashvi Verma, Mohd Faizan, Swati Goswami, et al.Pageof 692